Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relamorelin in Anorexia Nervosa
NCT01642550Phase 2Completed
- Sponsor
- Motus Therapeutics, Inc.
- Start
- Nov 2012
- Primary completion
- Mar 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in anorexia nervosa (AN) comparing RM-131 with Placebo (2 arms). Primary endpoint: Effect of RM-131 on body weight at Day 28. Started Nov 2012; status: completed.
02
Drugs
relamorelin
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT01642550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01642550.